Table 3 Levels of inflammatory proteins in paired samples before, compared with at four weeks of specific carbohydrate diet treatment in the seven patients with arthritis at inclusion
Chemokine pg/mla | At inclusion Md (IQR)b | At 4 weeks Md (IQR)b | Median difference | Confidence interval* | p-value** |
|---|---|---|---|---|---|
TNF-alpha | 1.8 (1.2–4.1) | 1.4 (1.0–3.9) | −0.3 | (− 0.5)–(− 0.1) | 0.03 |
TRAIL | 6.8 (6.7–6.9) | 6.7 (6.4–6.9) | −0.2 | (−0.4)–(− 0.04) | 0.03 |
MCP-1 | 11.2 (10.6–11.5) | 10.5 (10.4–10.8) | −0.5 | (−1.1)–(− 0.01) | 0.03 |
CX3CL1 | 4.8 (4.5–4.9) | 4.4 (4.0–4.6) | −0.3 | (−0.4)–(− 0.08) | 0.02 |
ADA | 2.1 (1.7–2.9) | 1.7 (1.4–2.6) | −0.4 | (−0.9)–(− 0.08) | 0.02 |
IL10RA | 0.3 (0.1–0.3) | 0.05 (−0.07–0.18) | −0.1 | (− 0.3)–(− 0.04) | 0.02 |
IL10RB | 5.1 (4.9–5.2) | 4.9 (4.8–5.0) | −0.2 | (−0.5)–(− 0.07) | 0.03 |
SCF | 8.6 (8.4–8.9) | 8.2 (7.6–8.5) | −0.5 | (−1.0)–(− 0.2) | 0.02 |
uPA | 9.8 (9.3–9.8 | 9.4 (9.3–9.7) | −0.1 | (−0.4)–(− 0.02) | 0.02 |